Wells Fargo’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.55M | Buy |
|
|||||
|
2025
Q1 | $1.64M | Buy |
|
|||||
|
2024
Q4 | $783K | Buy |
|
|||||
|
2024
Q3 | $517K | Sell |
|
|||||
|
2024
Q2 | $448K | Buy |
|
|||||
|
2024
Q1 | $318K | Buy |
|
|||||
|
2023
Q4 | $334K | Sell |
|
|||||
|
2023
Q3 | $1.36M | Sell |
|
|||||
|
2023
Q2 | $1.8M | Buy |
|
|||||
|
2023
Q1 | $1.53M | Buy |
|
|||||
|
2022
Q4 | $113K | Sell |
|
|||||
|
2022
Q3 | $216K | Sell |
|
|||||
|
2022
Q2 | $240K | Sell |
|
|||||
|
2022
Q1 | $2.52M | Sell |
|
|||||
|
2021
Q4 | $3M | Buy |
|
|||||
|
2021
Q3 | $2.89M | Sell |
|
|||||
|
2021
Q2 | $3.18M | Sell |
|
|||||
|
2021
Q1 | $2.05M | Sell |
|
|||||
|
2020
Q4 | $3.52M | Buy |
|
|||||
|
2020
Q3 | $1.61M | Sell |
|
|||||
|
2020
Q2 | $2.29M | Buy |
|
|||||
|
2020
Q1 | $184K | Sell |
|
|||||
|
2019
Q4 | $500K | Sell |
|
|||||
|
2019
Q3 | $544K | Buy |
|
|||||
|
2019
Q2 | $695K | Buy |
|
|||||
|
2019
Q1 | $696K | Buy |
|
|||||
|
2018
Q4 | $532K | Sell |
|
|||||
|
2018
Q3 | $517K | Buy |
|
|||||
|
2018
Q2 | $361K | Sell |
|
|||||
|
2018
Q1 | $324K | Buy |
|
|||||
|
2017
Q4 | $258K | Sell |
|
|||||
|
2017
Q3 | $507K | Buy |
|
|||||
|
2017
Q2 | $356K | Sell |
|
|||||
|
2017
Q1 | $673K | Sell |
|
|||||
|
2016
Q4 | $750K | Buy |
|
|||||
|
2016
Q3 | $125K | Buy |
|
|||||
|
2016
Q2 | $62K | Sell |
|
|||||
|
2016
Q1 | $103K | Buy |
|
|||||
|
2015
Q4 | $332K | Sell |
|
|||||
|
2015
Q3 | $526K | Sell |
|
|||||
|
2015
Q2 | $783K | Buy |
|
|||||
|
2015
Q1 | $376K | Buy |
|
|||||
|
2014
Q4 | $465K | Buy |
|
|||||
|
2014
Q3 | $321K | Buy |
|
|||||
|
2014
Q2 | $269K | Sell |
|
|||||
|
2014
Q1 | $418K | Buy |
|
|||||
|
2013
Q4 | $198K | Sell |
|
|||||
|
2013
Q3 | $247K | Buy |
|
|||||
|
2013
Q2 | $14K | Buy |
|